797 Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2 negative metastatic breast cancer

• Changhee Park,
• Yeon Hee Park,
• Seock-Ah Im,
• Jeehyun Kim,
• Koung Jin Suh,
• Se Hyun Kim,
• Min Hwan Kim,
• Jae Ho Jeong,
• Kyoung Eun Lee,
• Hee-Jun Kim,
• Eun Kyung Cho,
• In Sil Choi,
• Seung-Jae Noh,
• Inkyung Shin,
• Dae-Yeon Cho

Affiliations

Changhee Park

1Seoul National University Bundang Hospital, Seoul, Republic of Korea

Yeon Hee Park

6Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Seock-Ah Im

1Seoul National University Bundang Hospital, Seoul, Republic of Korea

Jeehyun Kim

2Seoul National University Bundang Hospital, Seongnam, Gyeonggi-Do, Republic of Korea

Koung Jin Suh

2Seoul National University Bundang Hospital, Seongnam, Gyeonggi-Do, Republic of Korea

Se Hyun Kim

2Seoul National University Bundang Hospital, Seongnam, Gyeonggi-Do, Republic of Korea

Min Hwan Kim

3Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea

Jae Ho Jeong

4Asan Medical Center, Seoul, Republic of Korea

Kyoung Eun Lee

5Ewha Womans University Hospital, Seoul, Republic of Korea

Hee-Jun Kim

7Chung-Ang University College of Medicine, Seoul, Republic of Korea

Eun Kyung Cho

8Gil Medical Center, Incheon, Republic of Korea

In Sil Choi

9Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea

Seung-Jae Noh

10PentaMedix Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea

Inkyung Shin

10PentaMedix Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea

Dae-Yeon Cho

10PentaMedix Co., Ltd., Seongnam, Gyeonggi-do, Republic of Korea